Skip to content
Join
Microbiomehub
Sign In
Search
  • Topics
    Scientific News
    Allergology
    Cardiology
    Dentistry
    Dermatology
    Endocrinology
    Gastroenterology
    Geriatrics
    Gynecology
    Infectiology
    Immunology
    Nephrology
    Neuroscience
    Nutrition
    Oncology
    Ophthalmology
    See all scientific news
    Industry news
    Tumor-dwelling bacteria boost effectiveness of cancer therapy in mice
    Microbiome therapy hits Phase 3 milestone: MaaT Pharma’s Xervyteg delivers in refractory GI-aGvHD ahead of ASH 2025 and EMA review
    Gut microbes help keep immune cells anchored in the intestine
    Breast milk antibodies train newborn gut immunity, mice study shows
    See all industry news
  • Archives
    Video interviews
    Microbiota, immunity, and the environment: towards an integrated One Health approach
    Microbiota and women’s health: emerging evidence and personalized perspectives
    See all video inteviews
    Webinars
    Supporting women’s health through menopause: probiotic insights from IFF Health
    Consumer behavior in probiotic consumption
    See all webinars
    Podcasts
    Gut-Brain Theory – Episode 3: Insomnia, anxiety and the microbiome
    Gut-Brain Theory – Episode 2: The link between gut and depression
    See all podcasts
    Companies Resources
    SynbiOFF® Line – Product List
    SynbÆctive® Formulations – Table of Life
    See all companies
  • MicrobiomeHUB

    Your go-to destination to spotlight your products and services while connecting with high-value leads in the microbiome space

    Partners
    Learn More
  • Probiotic database
    Probiotic strains
    Cardiometabolic
    Gastrointestinal
    Gut-brain Axis
    Healthy Ageing
    Immune System
    Oral Care
    Skin Health
    Sport
    Urogenital
    Weight Management
    Women's Health
    See all strains
    Latest probiotic blends
    Synbiotics by Probi® and Clasado
    Probi® Sensia
    SynbÆctive® KeepCalm
    SynbÆctive® MetSyn
    SynbÆctive® Wellderly
    SynbÆctive® ProBeautyShield
    SynbÆctive® Femme
    SynbÆctive® SmilinGut
    SynbÆctive® DefensePlus
    See all blends
  • Events
Newsletter

Home > Industry > Akkermansia municiphila on the market before the end of 2022

Akkermansia municiphila on the market before the end of 2022

author
Staff editor
author
12.04.2022
Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.

Latest related content

Oncology

Tumor-dwelling bacteria boost effectiveness of cancer therapy in mice

Industry

Microbiome therapy hits Phase 3 milestone: MaaT Pharma’s Xervyteg delivers in refractory GI-aGvHD ahead of ASH 2025 and EMA review

Gastroenterology, Immunology

Gut microbes help keep immune cells anchored in the intestine

Immunology, Pediatrics

Breast milk antibodies train newborn gut immunity, mice study shows

Video

Microbiota, immunity, and the environment: towards an integrated One Health approach

Scientific research

Gut bacteria studied at subspecies level reveal links to colorectal cancer

Latest News

Oncology

Tumor-dwelling bacteria boost effectiveness of cancer therapy in mice

Industry

Microbiome therapy hits Phase 3 milestone: MaaT Pharma’s Xervyteg delivers in refractory GI-aGvHD ahead of ASH 2025 and EMA review

Gastroenterology, Immunology

Gut microbes help keep immune cells anchored in the intestine

Immunology, Pediatrics

Breast milk antibodies train newborn gut immunity, mice study shows

Video

Microbiota, immunity, and the environment: towards an integrated One Health approach

Scientific research

Gut bacteria studied at subspecies level reveal links to colorectal cancer

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Subscribe
Microbiome Post
MicrobiomePost
  • Advertise with us
  • About us
  • Contact us
Microbiomehub
MicrobiomeHUB
  • What is MicrobiomeHUB
  • Help Center
Follow us
Linkedin X-twitter Facebook-f
© 2018-2025 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Scroll to Top
Sign In
Scientific News
Industry news
Video interviews
Webinars
Podcasts
Join
Companies
Probiotic strains
Probiotic blends
Event calendar
Sign Up for Free Microbiome Newsletter
Keep up to date with the latest business & market news on microbiome space with our free newsletter.

By submitting this form, you acknowledge that you have read and understand our Privacy Policy

X